首站-论文投稿智能助手
典型文献
Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory,anti-oxidative and anti-proliferative effects
文献摘要:
Inflammatory activation and oxidative stress promote the proliferation of vascular smooth muscle cells(VSMCs),which accounts for pathological vascular remodeling in hypertension.ELABELA(ELA)is the second endogenous ligand for angiotensin receptor-like 1(APJ)receptor that has been discovered thus far.In this study,we investigated whether ELA regulated VSMC proliferation and vascular remodeling in spontaneously hypertensive rats(SHRs).We showed that compared to that in Wistar-Kyoto rats(WKYs),ELA expression was markedly decreased in the VSMCs of SHRs.Exogenous ELA-21 significantly inhibited inflammatory cytokines and NADPH oxidase 1 expression,reactive oxygen species production and VSMC proliferation and increased the nuclear translocation of nuclear factor erythroid 2-related factor(Nrf2)in VSMCs.Osmotic minipump infusion of exogenous ELA-21 in SHRs for 4 weeks significantly decreased diastolic blood pressure,alleviated vascular remodeling and ameliorated vascular inflammation and oxidative stress in SHRs.In VSMCs of WKY,angiotensin Ⅱ(Ang Ⅱ)-induced inflammatory activation,oxidative stress and VSMC proliferation were attenuated by pretreatment with exogenous ELA-21 but were exacerbated by ELA knockdown.Moreover,ELA-21 inhibited the expression of matrix metalloproteinase 2 and 9 in both SHR-VSMCs and Ang Ⅱ-treated WKY-VSMCs.We further revealed that exogenous ELA-21-induced inhibition of proliferation and PI3K/Akt signaling were amplified by the PI3K/Akt inhibitor LY294002,while the APJ receptor antagonist F13A abolished ELA-21-induced PI3K/Akt inhibition and Nrf2 activation in VSMCs.In conclusion,we demonstrate that ELA-21 alleviates vascular remodeling through anti-inflammatory,anti-oxidative and anti-proliferative effects in SHRs,indicating that ELA-21 may be a therapeutic agent for treating hypertension.
文献关键词:
作者姓名:
Chao Ye;Zhi Geng;Ling-li Zhang;Fen Zheng;Ye-bo Zhou;Guo-qing Zhu;Xiao-qing Xiong
作者机构:
Key Laboratory of Targeted Intervention of Cardiovascular Disease,Department of Physiology,Nanjing Medical University,Nanjing 211166,China;Department of Cardiac Surgery,The Second Affiliated Hospital of Nanjing Medical University,Nanjing 211166,China;Department of Rheumatology and Immunology,Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University,Nanjing 211166,China
引用格式:
[1]Chao Ye;Zhi Geng;Ling-li Zhang;Fen Zheng;Ye-bo Zhou;Guo-qing Zhu;Xiao-qing Xiong-.Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory,anti-oxidative and anti-proliferative effects)[J].中国药理学报(英文版),2022(10):2573-2584
A类:
ELABELA,WKYs,minipump
B类:
Chronic,infusion,alleviates,vascular,remodeling,spontaneously,hypertensive,rats,anti,inflammatory,oxidative,proliferative,effects,Inflammatory,activation,stress,promote,proliferation,smooth,muscle,cells,VSMCs,which,accounts,pathological,hypertension,second,endogenous,ligand,angiotensin,receptor,like,APJ,that,has,been,discovered,thus,far,this,study,investigated,whether,regulated,SHRs,We,showed,compared,Wistar,Kyoto,expression,was,markedly,decreased,Exogenous,significantly,inhibited,cytokines,NADPH,oxidase,reactive,oxygen,species,production,increased,nuclear,translocation,erythroid,related,Nrf2,Osmotic,exogenous,weeks,diastolic,blood,pressure,alleviated,ameliorated,inflammation,Ang,induced,were,attenuated,by,pretreatment,but,exacerbated,knockdown,Moreover,matrix,metalloproteinase,both,treated,further,revealed,inhibition,PI3K,Akt,signaling,amplified,inhibitor,LY294002,while,antagonist,F13A,abolished,conclusion,demonstrate,through,indicating,may,therapeutic,agent,treating
AB值:
0.44482
相似文献
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
Influence of electroacupuncture on ghrelin and the phosphoinositide 3-kinase/protein kinase B/endothelial nitric oxide synthase signaling pathway in spontaneously hypertensive rats
Yue Zhang;Dong-ling Zhong;Ya-ling Zheng;Yu-xi Li;Yi-jie Huang;Yi-jing Jiang;Rong-jiang Jin;Juan Li-School of Health Preservation and Rehabilitation,Chengdu University of Traditional Chinese Medicine,Chengdu 610075,Sichuan Province,China;Department of Rehabilitation Medicine,The Second People's Hospital of Chengdu,Chengdu 610017,Sichuan Province,China;Department of Rehabilitation Medicine,The Seventh Affiliated Hospital of Sun Yat-Sen University,Shenzhen 518107,Guangdong Province,China;Department of Rehabilitation Medicine,Rehabilitation Hospital Affiliated to Fujian University of Traditional Chinese Medicine,Fuzhou 350003,Fujian Province,China
Taxifolin attenuates inflammation via suppressing MAPK signal pathway in vitro and in silico analysis
Xingyan Zhang;Xiaoyan Lian;Huling Li;Wenjing Zhao;Xin Li;Fujun Zhou;Yutong Zhou;Tao Cui;Yuli Wang;Changxiao Liu-Key Laboratory of Quality-marker of Traditional Chinese Medicines,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China;Department of Pharmacology,Tianjin Medical University,Tianjin 300070,China;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Key Laboratory of Systems Bioengineering(Ministry of Education),School of Chemistry Engineering and Technology,Tianjin University,Tianjin 300072,China;Pharmaceuticai Armaceuticai DA REN TANG Group Corporation Limited Traditional Chinese Pharmacy Researchinstitute,Tianjin 300457,China;Tianjin Key Laboratory of Quality Control in Chinese Medicine,Tianjin 300457,China;Research Unit for Drug Metabolism,Chinese Academy of Medical Sciences,Beijing 100730,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。